JPS5459317A - Immune preparation - Google Patents
Immune preparationInfo
- Publication number
- JPS5459317A JPS5459317A JP11984178A JP11984178A JPS5459317A JP S5459317 A JPS5459317 A JP S5459317A JP 11984178 A JP11984178 A JP 11984178A JP 11984178 A JP11984178 A JP 11984178A JP S5459317 A JPS5459317 A JP S5459317A
- Authority
- JP
- Japan
- Prior art keywords
- immune preparation
- immune
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/605—MHC molecules or ligands thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/807—Hapten conjugated with peptide or protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/838—Marrow; spleen
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4033977 | 1977-09-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5459317A true JPS5459317A (en) | 1979-05-12 |
Family
ID=10414407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11984178A Pending JPS5459317A (en) | 1977-09-28 | 1978-09-28 | Immune preparation |
Country Status (5)
Country | Link |
---|---|
US (1) | US4478823A (ja) |
EP (1) | EP0006916B1 (ja) |
JP (1) | JPS5459317A (ja) |
DE (1) | DE2860875D1 (ja) |
WO (1) | WO1979000160A1 (ja) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2487201B2 (fr) * | 1980-03-24 | 1985-07-05 | Pasteur Institut | Preparation lymphocytaires applicables en therapeutique humaine, procede d'obtention et applications |
US6818393B1 (en) | 1982-07-30 | 2004-11-16 | Biomirieux Sa | DNA sequences coding for the DR beta-chain locus of the human lymphocyte antigen complex and polypeptides, diagnostic typing processes and products related thereto |
EP0103960B1 (en) * | 1982-07-30 | 1991-01-23 | Mach, Bernard François, Prof. | Dna sequences coding for the dr beta-chain locus of the human lymphocyte antigen complex and polypeptides, diagnostic typing processes and products related thereto |
US5447722A (en) * | 1983-12-12 | 1995-09-05 | University Of Manitoba | Method for the suppression of an immune response with antigen-MPEG conjugates in nonsensitized individuals |
US4681760A (en) * | 1985-04-17 | 1987-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Method of conferring immunotolerance to a specific antigen |
US4689400A (en) * | 1985-06-27 | 1987-08-25 | The United States Of America As Represented By The Secretary Of The Navy | Enhancement of specific antibody production with anti-IgD antibodies |
ATE128627T1 (de) * | 1986-06-30 | 1995-10-15 | Massachusetts Inst Technology | Immunomodulare mittel und deren verwendung. |
US5019384A (en) * | 1986-06-30 | 1991-05-28 | Massachusetts Institute Of Technology | Immunonodulating compositions and their use |
US5554372A (en) * | 1986-09-22 | 1996-09-10 | Emory University | Methods and vaccines comprising surface-active copolymers |
WO1988001873A1 (en) * | 1986-09-22 | 1988-03-24 | Emory University | Vaccine and method of preparation |
EP0420913B1 (en) * | 1988-06-14 | 1995-11-15 | Cell Med, Inc. | Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same |
US5468481A (en) * | 1988-06-23 | 1995-11-21 | Amergen, Inc. | MHC class II-peptide conjugates useful in ameliorating autoimmunity |
US5130297A (en) * | 1988-06-23 | 1992-07-14 | Anergen, Inc. | Conjugates useful in ameliorating autoimmunity MHC-II-peptide |
US5260422A (en) * | 1988-06-23 | 1993-11-09 | Anergen, Inc. | MHC conjugates useful in ameliorating autoimmunity |
US5194425A (en) * | 1988-06-23 | 1993-03-16 | Anergen, Inc. | Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
DE3825615A1 (de) * | 1988-07-28 | 1990-02-01 | Behringwerke Ag | Antigenkonstrukte von "major histocompatibility complex" klasse i antigenen mit spezifischen traegermolekuelen, ihre herstellung und verwendung |
US5073540A (en) * | 1989-05-15 | 1991-12-17 | Receptron | Composite binding site drugs |
US5728388A (en) * | 1989-10-03 | 1998-03-17 | Terman; David S. | Method of cancer treatment |
US5364762A (en) * | 1990-03-21 | 1994-11-15 | Board Of Trustees Of The Leland Stanford Junior University | Major histocompatibility complex (MHC) molecules |
AU660278B2 (en) * | 1990-05-10 | 1995-06-22 | Dana-Farber Cancer Institute | Enhancing the association of exogenous peptides with class 1 MHC molecules on immune system cells |
US5733550A (en) * | 1990-05-10 | 1998-03-31 | Dana-Farber Cancer Institute, Inc. | Method for enhancing the association of exogenous peptides with class I MHC molecules on the surface of antigen presenting cells with β-microglobulin |
US5529934A (en) * | 1991-07-29 | 1996-06-25 | Biomide Investment Limited Partnership | Method for measuring blood procoagulant activity of human leukocyte antigens |
US5976551A (en) * | 1991-11-15 | 1999-11-02 | Institut Pasteur And Institut Nationale De La Sante Et De La Recherche Medicale | Altered major histocompatibility complex (MHC) determinant and method of using the determinant |
US6153408A (en) * | 1991-11-15 | 2000-11-28 | Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale | Altered major histocompatibility complex (MHC) determinant and methods of using the determinant |
US5734023A (en) * | 1991-11-19 | 1998-03-31 | Anergen Inc. | MHC class II β chain/peptide complexes useful in ameliorating deleterious immune responses |
US5583031A (en) * | 1992-02-06 | 1996-12-10 | President And Fellows Of Harvard College | Empty major histocompatibility class II heterodimers |
US6696061B1 (en) | 1992-08-11 | 2004-02-24 | President And Fellows Of Harvard College | Immunomodulatory peptides |
JPH08502244A (ja) * | 1992-08-11 | 1996-03-12 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 免疫調節ペプチド |
EP0671926B1 (en) | 1992-08-11 | 2002-11-13 | President And Fellows Of Harvard College | Immunomodulatory peptides |
WO1994025054A1 (en) * | 1993-04-29 | 1994-11-10 | Andrew Atkin | Recombinant vaccine |
AU7958994A (en) * | 1993-10-05 | 1995-05-01 | Ludwig Institute For Cancer Research | Method for provoking immunity by peptides labelled with a photoactivatable group which binds to mhc molecules |
US5820866A (en) * | 1994-03-04 | 1998-10-13 | National Jewish Center For Immunology And Respiratory Medicine | Product and process for T cell regulation |
US5453533A (en) * | 1994-04-14 | 1995-09-26 | The University Of Alabama At Birmingham | Inhibitors of influenza virus neuraminidase and methods of making and using the same |
US5985859A (en) * | 1994-04-14 | 1999-11-16 | The University Of Alabama | Methods of inhibiting bacterial sialidase |
AU2361595A (en) * | 1994-04-22 | 1995-11-16 | Sloan-Kettering Institute For Cancer Research | Induction of cytotoxic t lymphocytes (ctl) using antigenic peptides and a suitable adjuvant |
WO1995031472A1 (en) * | 1994-05-18 | 1995-11-23 | Board Of Regents, The University Of Texas System | Chimeric mhc class i antigens for inducing allograft tolerance |
WO1995034321A1 (en) * | 1994-06-16 | 1995-12-21 | The Board Of Trustees Of The Leland Stanford Junior University | Immune modulation with class ii alpha-chain fragments |
US5935797A (en) * | 1994-06-16 | 1999-08-10 | Stanford University | Interaction of MHC Class II proteins with members of the PCNA family of proteins |
US5635363A (en) * | 1995-02-28 | 1997-06-03 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for the detection, quantitation and purification of antigen-specific T cells |
JPH09151200A (ja) | 1995-09-29 | 1997-06-10 | Ajinomoto Co Inc | ヒト胃癌に対する免疫応答を誘導できるペプチド及び該ペプチドを含むヒト胃癌治療、予防剤 |
AU712820B2 (en) * | 1996-03-19 | 1999-11-18 | University Of Virginia Patent Foundation | Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytotoxic lymphocytes, and uses therefor |
US7019112B1 (en) | 1996-03-19 | 2006-03-28 | University Of Virginia Patent Foundation | Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses therefor |
US6709873B1 (en) * | 1997-04-09 | 2004-03-23 | Isodiagnostika Inc. | Method for production of antibodies to specific sites of rapamycin |
US6248564B1 (en) | 1997-08-29 | 2001-06-19 | Harvard University | Mutant MHC class I molecules |
WO1999045018A1 (en) * | 1998-03-06 | 1999-09-10 | Imclone Systems Incorporated | Active immunization against angiogenesis-associated antigens |
EP1123086B1 (en) | 1998-10-20 | 2010-03-03 | Androclus Technologies S.r.l. in liquidazione | Artificial antigen-specific cells and related methods |
US7807377B2 (en) | 1998-10-20 | 2010-10-05 | Salvatore Albani | Method of isolating antigen-specific T cells employing artificial antigen presenting cells |
US6787154B2 (en) * | 1998-10-20 | 2004-09-07 | Salvatore Albani | Artificial antigen presenting cells |
US20030199024A1 (en) * | 2002-04-19 | 2003-10-23 | Hansen Ted H. | Single chain trimers of class I MHC molecules |
WO2005040197A1 (en) * | 2003-10-24 | 2005-05-06 | Invitrogen Corporation | Compositions, methods and kits for biarsenical fluorophore labeling |
US8518697B2 (en) * | 2006-04-04 | 2013-08-27 | Washington University | Single chain trimers and uses therefor |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1945251A1 (de) * | 1969-09-06 | 1971-03-11 | Karl Dr Med Theurer | Verfahren zur Beeinflussung der quantitativen Antikoerperbildung bei der aktiven Immunisierung und der Desensibilisierung |
US4185090A (en) * | 1972-02-02 | 1980-01-22 | Abbott Laboratories | Chemically modified endotoxin immunizing agent |
JPS56500298A (ja) * | 1979-03-27 | 1981-03-12 | ||
US4372945A (en) * | 1979-11-13 | 1983-02-08 | Likhite Vilas V | Antigen compounds |
-
1978
- 1978-09-27 DE DE7878900128T patent/DE2860875D1/de not_active Expired
- 1978-09-27 WO PCT/GB1978/000016 patent/WO1979000160A1/en unknown
- 1978-09-27 EP EP78900128A patent/EP0006916B1/en not_active Expired
- 1978-09-28 JP JP11984178A patent/JPS5459317A/ja active Pending
-
1983
- 1983-01-10 US US06/456,976 patent/US4478823A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1979000160A1 (en) | 1979-04-05 |
US4478823A (en) | 1984-10-23 |
EP0006916B1 (en) | 1981-07-08 |
EP0006916A1 (en) | 1980-01-23 |
DE2860875D1 (en) | 1981-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5459317A (en) | Immune preparation | |
GB2009771B (en) | Vaccine | |
AU3491878A (en) | The preparation of iodophorcompounds | |
IE781591L (en) | Preparation of oligo-imides. | |
JPS53137787A (en) | Cup | |
ZA786760B (en) | Cosmetic preparation | |
JPS53143475A (en) | Percolator | |
GB2007118B (en) | Cyclone | |
GB2001530B (en) | Vaccine | |
JPS548719A (en) | Immune composition | |
JPS5449335A (en) | Cosmetic preparation | |
DE2860583D1 (en) | Stabilized cholesterol-oxidase preparation | |
JPS53113010A (en) | Immune examination | |
GB2004744B (en) | Immonulogical preparations | |
GB2010833B (en) | Homoerburnamine preparation | |
JPS5480408A (en) | Comosite vaccine | |
JPS5467045A (en) | Instant potage food | |
JPS53118593A (en) | Immune stimulating agent | |
JPS53113011A (en) | Immune examination | |
JPS5444014A (en) | Solid preparation unit | |
JPS5431368A (en) | Toaster | |
JPS52152373A (en) | Toaster | |
JPS5498315A (en) | Secretine preparation | |
IL52887A0 (en) | The preparation of bis-cycloalkenopyridines | |
JPS5414871A (en) | Cooker |